Cargando…

Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial

BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Weiqi, Xia, Hui, Zhang, Kai, Zhang, Yihan, Tao, Changcheng, Wu, Fan, Wang, Liming, Zhang, Hong, Sun, Guiju, Wu, Jianxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745621/
https://www.ncbi.nlm.nih.gov/pubmed/36523946
http://dx.doi.org/10.21037/hbsn-21-116
_version_ 1784849188344823808
author Rong, Weiqi
Xia, Hui
Zhang, Kai
Zhang, Yihan
Tao, Changcheng
Wu, Fan
Wang, Liming
Zhang, Hong
Sun, Guiju
Wu, Jianxiong
author_facet Rong, Weiqi
Xia, Hui
Zhang, Kai
Zhang, Yihan
Tao, Changcheng
Wu, Fan
Wang, Liming
Zhang, Hong
Sun, Guiju
Wu, Jianxiong
author_sort Rong, Weiqi
collection PubMed
description BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities, such as inhibiting angiotensin I-converting enzyme, resisting lipid peroxidation and anti-oxidant. However, the correlation between COPs and liver cancer patients is still unknown and the potential mechanism of COPs on liver cancer is unclear as well. The aim of this study was to assess effects of 7-day intervention of COPs after surgery on liver function and serum metabolic profiles of liver cancer patients. METHODS: Patients were assigned into COPs intervention group (n=50) and control group (n=91) for 7 days. Investigations were scheduled at 1(st) day and 7(th) day after liver resection surgery respectively, mainly including anthropometric, biochemical indexes and liquid chromatography-mass spectrometry (LC/MS) analysis. RESULTS: Seven-day supplementation of COPs on early post-surgery liver cancer patients down-regulated levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin and up-regulated prothrombin time activity and prealbumin levels. LC/MS analysis revealed metabolic signatures including regulation of 16 metabolites, which was closely related with two metabolic pathways (nicotinate and nicotinamide metabolism, fatty acid metabolism). CONCLUSIONS: COPs supplementation has displayed the potentials on alleviating the injury of liver function and it may be due to regulation of fatty acid metabolism, nicotinate and nicotinamide metabolism, lipid peroxidation and anti-inflammatory action. More researches are warranted in future to confirm the exact mechanisms.
format Online
Article
Text
id pubmed-9745621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97456212022-12-14 Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial Rong, Weiqi Xia, Hui Zhang, Kai Zhang, Yihan Tao, Changcheng Wu, Fan Wang, Liming Zhang, Hong Sun, Guiju Wu, Jianxiong Hepatobiliary Surg Nutr Original Article BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities, such as inhibiting angiotensin I-converting enzyme, resisting lipid peroxidation and anti-oxidant. However, the correlation between COPs and liver cancer patients is still unknown and the potential mechanism of COPs on liver cancer is unclear as well. The aim of this study was to assess effects of 7-day intervention of COPs after surgery on liver function and serum metabolic profiles of liver cancer patients. METHODS: Patients were assigned into COPs intervention group (n=50) and control group (n=91) for 7 days. Investigations were scheduled at 1(st) day and 7(th) day after liver resection surgery respectively, mainly including anthropometric, biochemical indexes and liquid chromatography-mass spectrometry (LC/MS) analysis. RESULTS: Seven-day supplementation of COPs on early post-surgery liver cancer patients down-regulated levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin and up-regulated prothrombin time activity and prealbumin levels. LC/MS analysis revealed metabolic signatures including regulation of 16 metabolites, which was closely related with two metabolic pathways (nicotinate and nicotinamide metabolism, fatty acid metabolism). CONCLUSIONS: COPs supplementation has displayed the potentials on alleviating the injury of liver function and it may be due to regulation of fatty acid metabolism, nicotinate and nicotinamide metabolism, lipid peroxidation and anti-inflammatory action. More researches are warranted in future to confirm the exact mechanisms. AME Publishing Company 2022-12 /pmc/articles/PMC9745621/ /pubmed/36523946 http://dx.doi.org/10.21037/hbsn-21-116 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Rong, Weiqi
Xia, Hui
Zhang, Kai
Zhang, Yihan
Tao, Changcheng
Wu, Fan
Wang, Liming
Zhang, Hong
Sun, Guiju
Wu, Jianxiong
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title_full Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title_fullStr Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title_full_unstemmed Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title_short Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
title_sort serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745621/
https://www.ncbi.nlm.nih.gov/pubmed/36523946
http://dx.doi.org/10.21037/hbsn-21-116
work_keys_str_mv AT rongweiqi serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT xiahui serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT zhangkai serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT zhangyihan serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT taochangcheng serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT wufan serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT wangliming serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT zhanghong serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT sunguiju serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial
AT wujianxiong serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial